Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

NCT00256217 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

DCIS

Interventions

DRUG: Anastrozole

Sponsor

Rita Sanghvi, Mehta

Collaborators

[object Object]